Trognon Jeanne, Vera Gonzalo, Rima Maya, Stigliani Jean-Luc, Amielet Laurent, El Hage Salomé, Lajoie Barbora, Roques Christine, El Garah Fatima
Laboratoire de Génie Chimique, Université de Toulouse, CNRS, INPT, UPS, 31062 Toulouse, France.
Laboratoire de Chimie de Coordination, Université de Toulouse, CNRS, INPT, UPS, 31062 Toulouse, France.
Pharmaceuticals (Basel). 2022 Mar 29;15(4):417. doi: 10.3390/ph15040417.
Biofilm formation is considered a major cause of therapeutic failure because bacteria in biofilms have higher protection against antimicrobials. Thus, biofilm-related infections are extremely challenging to treat and pose major concerns for public health, along with huge economic impacts. Pseudomonas aeruginosa, in particular, is a “critical priority” pathogen, responsible for severe infections, especially in cystic fibrosis patients because of its capacity to form resistant biofilms. Therefore, new therapeutic approaches are needed to complete the pipeline of molecules offering new targets and modes of action. Biofilm formation is mainly controlled by Quorum Sensing (QS), a communication system based on signaling molecules. In the present study, we employed a molecular docking approach (Autodock Vina) to assess two series of chromones-based compounds as possible ligands for PqsR, a LuxR-type receptor. Most compounds showed good predicted affinities for PqsR, higher than the PQS native ligand. Encouraged by these docking results, we synthesized a library of 34 direct and 25 retro chromone carboxamides using two optimized routes from 2-chromone carboxylic acid as starting material for both series. We evaluated the synthesized carboxamides for their ability to inhibit the biofilm formation of P. aeruginosa in vitro. Overall, results showed several chromone 2-carboxamides of the retro series are potent inhibitors of the formation of P. aeruginosa biofilms (16/25 compound with % inhibition ≥ 50% at 50 μM), without cytotoxicity on Vero cells (IC50 > 1.0 mM). The 2,4-dinitro-N-(4-oxo-4H-chromen-2-yl) benzamide (6n) was the most promising antibiofilm compound, with potential for hit to lead optimization.
生物膜形成被认为是治疗失败的主要原因,因为生物膜中的细菌对抗菌剂具有更高的抵抗力。因此,与生物膜相关的感染极难治疗,对公共卫生构成重大担忧,同时还会产生巨大的经济影响。特别是铜绿假单胞菌是一种“关键优先”病原体,可导致严重感染,尤其是在囊性纤维化患者中,因为它能够形成耐药生物膜。因此,需要新的治疗方法来完善提供新靶点和作用模式的分子管线。生物膜形成主要受群体感应(QS)控制,群体感应是一种基于信号分子的通讯系统。在本研究中,我们采用分子对接方法(Autodock Vina)评估了两系列基于色酮的化合物作为LuxR型受体PqsR的可能配体。大多数化合物对PqsR显示出良好的预测亲和力,高于PQS天然配体。受这些对接结果的鼓舞,我们以2-色酮羧酸为起始原料,通过两条优化路线合成了一个包含34种直接色酮羧酰胺和25种反向色酮羧酰胺的文库。我们评估了合成的羧酰胺在体外抑制铜绿假单胞菌生物膜形成的能力。总体而言,结果表明反向系列的几种色酮-2-羧酰胺是铜绿假单胞菌生物膜形成的有效抑制剂(25种化合物中有16种在50μM时抑制率≥50%),对Vero细胞无细胞毒性(IC50>1.0 mM)。2,4-二硝基-N-(4-氧代-4H-色烯-2-基)苯甲酰胺(6n)是最有前景的抗生物膜化合物,具有从苗头化合物优化到先导化合物的潜力。